P-76: The Effect of Maternal and Paternal Body Mass Index on Live Births after Intracytoplasmic Sperm Injection (ICSI) Cycles
Authors
Abstract:
Background The present study was designed to investigate the effect of couple`s obesity simultaneously on ART outcomes MaterialsAndMethods This cross-sectional study was performed in Royan institute between September 2012 and January 2014. The recorded data of all patients during this time period were evaluated. The study population was limited to ICSI or IVF/ICSI cycles with autologous oocytes and fresh embryos transfer, which height and weight in both gender recorded. Moreover multilevel logistic regression analysis was used to determine the odds of live birth following ICSI cycles. The analysis was performed according to female and male body mass index (BMI) groups whereas normal–weight patients were considered as reference group. Multilevel logistic regression was performed as couple analyses. Results In total, 990 women and their husbands went through 927 treatment ICSI and 63 IVF/ICSI cycles during study period. Among ovulatory women, a significant difference between BMI groups was found, with 60% (95% CI: 0.11-0.83) and 84% (CI: 0.02-0.99) decrease in odds of live birth among overweight and obese, respectively. Among anovulatory women, the association between BMI and live birth presented no clear tendencies. About men, the results presented no significant relationship between BMI and live birth. The results revealed that there is no significant association between couples’ BMI and live birth rate. Conclusion Increased female BMI independently and negatively influenced live birth after ICSI treatments, but increased male BMI both independently and combined had no impact on live birth after ICSI treatments.
similar resources
The Effects of Maternal and Paternal Body Mass Index on Live Birth Rate after Intracytoplasmic Sperm Injection Cycles
Objective The present study was designed to evaluate the effect of couple`s obesity simultaneously on in-vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) outcomes. MaterialsAndMethods This cross-sectional study was performed in Royan institute between January 2013 and January 2014. The recorded data of all patients during this time period were evaluated. The study population was ...
full textPaternal origin of trisomy 21 following intracytoplasmic sperm injection (ICSI).
One important aspect in the debate on the genetic risks associated with intracytoplasmic sperm injection (ICSI) is the possible increased rate of chromosomal abnormalities in resulting pregnancies. ICSI was performed in a 27 year old man with asthenoteratozoospermia and his 25 year old wife. There was a spontaneous miscarriage at 9 weeks of gestation. Cytogenetic investigation revealed trisomy ...
full textIntracytoplasmic sperm injection (ICSI)
IVF has become a well-established treatment for certain types of infertility, including long-standing infertility due to tubal disease, endometriosis, unexplained infertility or infertility involving a male factor. Soon it became clear that certain couples with severe male-factor infertility could not be helped by conventional IVF. Extremely low sperm counts, impaired motility and/or abnormal m...
full textP-63: The Effect of Bromocriptine Rebound Method on Ongoing Pregnancy and Live Birth after Intracytoplasmic Sperm Injection Cycles: A Randomized Prospective Clinical Trial
Background: To assess whether Bromocriptine Rebound Method (BRM), can improve pregnancy outcomes after intracytoplasmic sperm injection (ICSI) cycles. Materials and Methods: In this prospective study, we analyzed data from a total of 117 women who underwent ICSI cycles. Pregnancy outcomes and hormonal data were compared between long protocol and BRM groups. Ovulatory women with normal serum pro...
full textLive births after intracytoplasmic sperm injection in the management of oligospermia and azoospermia in Nigeria.
Intracytoplasmic sperm injection has revolutionised the management of male infertility. We report two cases that demonstrate the successful application of this technology in Nigeria in the management of both oligospermia and azoospermia. The first case relates to the treatment of a 31-year-old woman who required intracytoplasmic sperm injection of her husband's sperm for the treatment of both t...
full textMy Resources
Journal title
volume 9 issue 2
pages 75- 75
publication date 2015-09-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023